
Ondine Biomedical has reported a 40% relative reduction in 30-day surgical-site infections (SSIs) in a 5,188-patient phase 3 trial of …
Aiforia deal to expand access to pathology AI
SMC accepts atogepant for acute migraine treatment in Scotland
New CCO Ogburn joins Cori Clinical

